This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Linda Sygowski: Innovator in T Cell Mediated Condition Treatments
Introduction
Linda Sygowski is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of medical research, particularly in the development of treatments for T cell mediated conditions.
Latest Patents
Sygowski holds a patent for "Cd45 inhibitors - Substituted naphthalenediones in accord with structural diagram (I): compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection." This innovative patent outlines compounds that can be utilized in treating various medical conditions, showcasing her expertise in medicinal chemistry.
Career Highlights
Throughout her career, Linda has demonstrated a commitment to advancing medical science. Her work at AstraZeneca AB has positioned her as a key player in the pharmaceutical industry, where she continues to explore new therapeutic avenues.
Collaborations
Linda has collaborated with notable colleagues, including Marc Chapdelaine and Katherine Knappenberger. These partnerships have further enriched her research and contributed to the success of her projects.
Conclusion
Linda Sygowski's innovative work in the field of T cell mediated conditions exemplifies her dedication to improving healthcare through scientific advancements. Her contributions are invaluable to the ongoing research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile